17-alpha-hydroxyprogesterone has been researched along with Disease, Pulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartoshesky, L; Mackley, A; Pau, DA | 1 |
| Cook, KL; Gerdes, JS; Watterberg, KL | 1 |
1 trial(s) available for 17-alpha-hydroxyprogesterone and Disease, Pulmonary
| Article | Year |
|---|---|
Impaired glucocorticoid synthesis in premature infants developing chronic lung disease.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Chronic Disease; Cortodoxone; Dexamethasone; Double-Blind Method; Glucocorticoids; Humans; Hydrocortisone; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Lung Diseases; Prospective Studies | 2001 |
1 other study(ies) available for 17-alpha-hydroxyprogesterone and Disease, Pulmonary
| Article | Year |
|---|---|
Newborn screening levels of 17-hydroxyprogesterone in very low birth weight infants and the relationship to chronic lung disease.
Topics: 17-alpha-Hydroxyprogesterone; Biomarkers; Birth Weight; Blood Pressure; Chronic Disease; Cohort Studies; Female; Gestational Age; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Lung Diseases; Male; Neonatal Screening; Oxygen; Oxygen Consumption; Pulmonary Alveoli; Respiration, Artificial; Respiratory Function Tests; Treatment Outcome | 2006 |